RankAlpha logo
Back to Rankings

NAMS

NewAmsterdamF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
NAMS vs peer average
15/100
NAMS vs. peer average (F vs. B)
Grade spread
A 1 · B 3 · C 3 · D 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ARQT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $3.44B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerARQTArcutis Biotherapeutics
NAMS
NewAmsterdam
ARQT
Arcutis Biotherapeutics
Grade
F
B
Momentum
23
84
Value
41
49
Sentiment
-
44
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs ARQT

NAMS / ARQT
Grade Position
Below peers
NAMS vs. peer average (F vs. B)
15/100
Momentum
23
ARQT
Value
41
ARQT
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NAMS
1
ARQT
Arcutis Biotherapeutics Inc Common
B
80/100
-3
2
ADPT
Adaptive Biotechnologies Corp Common
C
60/100
-2
3
OGN
Organon & Co Common
B
80/100
-3
4
RCUS
Arcus Biosciences Inc Common
C
60/100
-2
5
TLX
Telix Pharmaceuticals Ltd ADR
C
60/100
-2
ARQT is the first peer returned for this comparison set.